Mode
Text Size
Log in / Sign up

Cutting balloon predilatation shows lower acute recoil and stenosis compared to standard balloonCutting Balloons May Improve Vessel Opening in Heart Procedures

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that cutting balloon predilatation reduces acute recoil and stenosis but does not significantly improve optimal lesion preparation.

This randomized trial enrolled 201 patients with de novo coronary lesions suitable for a DCZ-only strategy across 19 Japanese centers. The study compared cutting balloon (CB) predilatation to standard balloon (SB) predilatation.

Primary outcome analysis showed no significant difference in optimal lesion preparation between the CB group (35.6%) and the SB group (30.0%), with an adjusted risk ratio of 1.19 (95% confidence interval 0.87-1.65, p = 0.28). Secondary outcomes showed that CB predilatation resulted in significantly lower acute recoil (1.18 ± 0.36 mm vs 1.31 ± 0.50 mm, p = 0.03) and lower residual diameter stenosis (30.8% ± 11.8% vs 34.5% ± 13.3%, p = 0.04) compared to SB. There was no significant difference in the avoidance of flow-limiting dissection (98.0% vs 97.0%).

While CB predilatation showed trends toward larger lumen dimensions on IVUS, the clinical significance of these acute angiographic advantages is not confirmed. The study is limited by the lack of reported follow-up data and the need for larger trials to confirm long-term clinical outcomes. CB predilatation provided modest angiographic advantages but did not significantly increase the rate of optimal lesion preparation.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in the technical nuances of coronary intervention techniques. While previous coverage has focused on surgical modalities like robotic versus traditional coronary artery bypass grafting, and diagnostic tools like AI-enhanced CCTA or 80 kV CTCA, this study specifically addresses the acute angiographic outcomes of cutting balloon versus standard balloon predilatation in coronary artery disease.

Researchers conducted a randomized trial involving 201 patients with coronary artery disease. The study compared two methods of preparing the artery before placing a stent: using a cutting balloon (CB) versus a standard balloon (SB). The goal was to see which method better prepared the lesion for the procedure.

The results showed that while the cutting balloon group had lower rates of acute recoil and lower residual diameter stenosis, it did not significantly increase the rate of optimal lesion preparation compared to the standard balloon. Both methods were very effective at avoiding flow-limiting dissections, with success rates of 98.0% and 97.0% respectively.

Because this study is relatively small and focused on immediate results, the findings are limited. The researchers noted that the clinical importance of these small differences in vessel size needs to be confirmed by larger trials and longer follow-up periods. Patients should discuss these technical options with their doctors to determine the best approach for their specific heart condition.

What this means for you:
Cutting balloons showed some technical advantages in vessel size but did not significantly improve overall preparation.

Common questions

What is the difference between a cutting balloon and a standard balloon?

A cutting balloon is used to prepare a coronary artery before placing a stent. In this study of 201 patients, the cutting balloon showed lower rates of acute recoil (1.18 mm vs 1.31 mm) and lower residual diameter stenosis (30.8% vs 34.5%) compared to a standard balloon. Both types were highly effective at avoiding flow-limiting dissections.

Does a cutting balloon make the procedure more successful?

The study found that while the cutting balloon provided some technical advantages in vessel expansion, it did not significantly increase the rate of optimal lesion preparation compared to a standard balloon. Because the study is small, these results are not yet enough to confirm a major change in standard clinical practice.

Is it safer to use a cutting balloon for heart procedures?

The study did not report any specific safety concerns or serious adverse events for either method. Both the cutting balloon and the standard balloon had very high success rates in avoiding flow-limiting dissections (98.0% and 97.0% respectively). You should talk to your doctor about which technique is best for your specific case.

Study Details

Study typeRct
Sample sizen = 201
EvidenceLevel 2
PublishedOct 2026
View Original Abstract ↓
The success of drug-coated balloon (DCB) therapy for de novo coronary lesions relies on optimal lesion preparation. However, evidence supporting the use of cutting balloons (CBs) for lesion preparation in DCB-only strategies remains limited. The NATURE trial assessed the effectiveness of CB compared with standard balloon (SB) predilatation in achieving optimal lesion preparation for a DCB-only strategy. The NATURE trial was a prospective, multicentre, randomised study conducted at 19 Japanese centres. Patients with de novo coronary lesions suitable for a DCB-only strategy were randomised (1:1) to lesion preparation with CB or SB. Post-predilatation assessment included coronary angiography, intravascular ultrasound (IVUS), and fractional flow reserve (FFR). The primary endpoint was optimal lesion preparation, defined as the simultaneous presence of: (1) no flow-limiting dissection, (2) residual diameter stenosis ≤ 30% by quantitative coronary angiography, and (3) FFR > 0.80. Among 201 patients included in the intention-to-treat population, optimal lesion preparation was achieved in 35.6% of the CB group and 30.0% of the SB group (adjusted risk ratio 1.19, 95% confidence interval 0.87-1.65; p = 0.28). Avoidance of flow-limiting dissection was high in both groups (98.0% vs 97.0%). CB predilatation resulted in lower residual diameter stenosis (30.8 ± 11.8% vs 34.5 ± 13.3%; p = 0.04) and less acute recoil (1.18 ± 0.36 vs 1.31 ± 0.50 mm; p = 0.03). Trends towards larger lumen dimensions on IVUS were also observed with CB. In patients undergoing DCB-only PCI for de novo coronary lesions, CB predilatation provided modest angiographic advantages compared with SB but did not significantly increase the rate of optimal lesion preparation. Optimal lesion preparation is essential for successful drug-coated balloon (DCB) therapy because DCBs do not provide mechanical scaffolding to maintain vessel patency. In this multicentre randomised trial, cutting balloon predilatation resulted in greater acute luminal expansion and less recoil than standard balloon predilatation, although it did not significantly increase the overall rate of optimal lesion preparation defined by angiographic and physiological criteria. These findings suggest that cutting balloons may offer modest mechanical advantages during lesion preparation in DCB-only PCI. However, the clinical significance of these acute angiographic advantages requires confirmation in larger trials and through longer-term follow-up.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.